Genetic polymorphism of drug metabolizing enzymes and estrogen receptor in pharmacogenetics of tamoxifen: implication for optimization of breast cancer treatment / Teh Lay Kek and Mohd Zaki Salleh
Introduction: Tamoxifen has been used as a hormonal therapy in breast cancer patients who are positive for estrogen receptor. The drug is metabolized by Cytochrome P450 2D6 (CYP2D6) into several metabolite. Variation in CYP2D6 activity has important therapeutic consequences and can play a significan...
Main Authors: | Lay Kek, Teh, Salleh, Mohd Zaki |
---|---|
Format: | Research Reports |
Language: | English |
Published: |
Research Management Institute (RMI)
2010
|
Subjects: | |
Online Access: | http://ir.uitm.edu.my/id/eprint/24806/ http://ir.uitm.edu.my/id/eprint/24806/1/LP_TEH%20LAY%20KEK%20RMI%2010_5.pdf |
Similar Items
-
Cancerpharmacogenomics: the relevance of genetic
profile in optimization drug therapy for azathiopurine and
5-Fluorouracil / Teh Lay Kek And Mohd Zaki Salleh
by: Teh, Lay Kek, et al.
Published: (2010) -
Cancer pharmacogenomics: the relevance of genetic profile in optimization drug therapy for azathiopurine and 5-fluorouracil / Prof Madya Dr Teh Lay Kek and Prof Dr Mohd Zaki Salleh
by: Teh, Lay Kek, et al.
Published: (2010) -
Transgenerational epigenetics in substance abuse: exploring the inheritable DNA methylation underlying the agressive behaviour and altered stress response. / Professor Dr Teh Lay Kek, Professor Dr Mohd Zaki Salleh and Dr. Richard Muhammad Johari James
by: Lay Kek, Teh, et al.
Published: (2016) -
The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism
by: Wan Sulaiman, Wan Mohd. Azizi, et al.
Published: (2011) -
Elevated expression of CD151 gene in estrogen receptor and progesterone receptor positive breast carcinoma
by: Ivyna Bong PN,, et al.
Published: (2011)